PVI
NEO icon

Pura Vida Investments’s NeoGenomics NEO Stock Holding History

Pura Vida Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-177,778
Closed -$6.96M – 286
2021
Q3 		$8.58M Buy
+177,778
New +$8.23M 0.26% 104

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Pura Vida Investments's NEO Position: Q4 2021 in Review

Pura Vida Investments sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 177,778 shares — an estimated $6.96M sold.

Pura Vida Investments first reported a position in NEO in Q3 2021 and held it in 1 quarter. The position peaked at $8.58M in Q3 2021. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Pura Vida Investments reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 177,778 NeoGenomics shares in Q4 2021, an estimated $6.96M.
  • Pura Vida Investments first reported a position in NeoGenomics in Q3 2021 and held it in 1 quarter.
  • Pura Vida Investments's NeoGenomics position peaked at $8.58M in Q3 2021.
  • 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.